Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,932
Closed -$275K 60
2023
Q4
$275K Sell
1,932
-385
-17% -$51.3K 0.01% 34
2023
Q3
$304K Buy
+2,317
New +$352K 0.01% 24
2022
Q3
Sell
-1,610
Closed -$227K 42
2022
Q2
$227K Sell
1,610
-804
-33% -$115K 0.01% 29
2022
Q1
$336K Buy
+2,414
New +$370K 0.01% 24

Other funds holding CLX

Meritage Group's CLX Position: Q1 2024 in Review

Meritage Group sold out of Clorox (CLX) in Q1 2024, closing a stake of 1,932 shares — an estimated $275K sold.

Meritage Group first reported a position in CLX in Q1 2022 and held it in 4 quarters. The position peaked at $336K in Q1 2022. 1,143 funds tracked by Wall St. Rank hold CLX as of Q1 2024.

  • Meritage Group reported no remaining Clorox position as of Q1 2024 after selling out during the quarter.
  • Meritage Group sold 1,932 Clorox shares in Q1 2024, an estimated $275K.
  • Meritage Group first reported a position in Clorox in Q1 2022 and held it in 4 quarters.
  • Meritage Group's Clorox position peaked at $336K in Q1 2022.
  • 1,143 funds tracked by Wall St. Rank held Clorox as of Q1 2024.

Based on Meritage Group's 13F filing for Q1 2024, filed 13 May 2024.